The FY2023-1 Small Business Innovation Research Contract (SBIR) Program solicitation has been posted!
“The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invite small business concerns (SBCs) to submit research proposals under this Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas described in Section 12.0, and to commercialize the results of that R&D, are encouraged to participate.”
Please see link above for specific solicitations.
There is a webinar scheduled for Sept 27th, at 1pm ET hosted by NIH. Register here.
Contract funding is very different from grant funding, and a project needs to be a very (very) good fit to pursue this mechanism. NIAID offers a useful resource to compare differences between grants and contracts – although written specifically for NIAID, these guidelines generally apply across NIH contracts.
Wondering if your company could win non-dilutive funding through an SBIR contract? Have questions about understanding the solicitation details? Reach out today and we will connect you with one of our experts!
- FY2023 NIH SBIR Contract Topics:
TOPIC NUMBER PHASE I ALLOWED? FAST TRACK ALLOWED?
(A Phase I proposal and a Phase II proposal submitted simultaneously)
DIRECT TO PHASE II ALLOWED?
(Includes only a Phase II Proposal)
TOPIC TITLE NIH/NCATS 024 Yes No No Small Manufacturing Systems to Produce Research Grade Pharmaceutical Intermediates NIH/NCI 455
Yes Yes Yes Point-of-Care Detection of Prostate Specific Antigen NIH/NCI 456
No Yes Yes Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control
NIH/NCI 457
Yes Yes No Technologies for Detecting Tumor-Derived Cell Clusters
NIH/NCI 458
Yes No No Microbiome-Based Tests for Cancer Research, Diagnosis, Prognosis and/or Patient Management
NIH/NCI 459
Yes Yes No Automated Software for Point-of-Care Testing to Identify Cancer-Associated Malnutrition
NIH/NCI 460
Yes No No Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies
NIH/NCI 461
Yes Yes Yes Ultra-Fast Dose Rate (FLASH) Radiation Detectors and Safety Systems for Cancer Treatment
NIH/NCI 462
Yes Yes Yes Organ-on-Chip for Preclinical and Translational Radiobiological Studies
NIH/NCI 463
Yes Yes Yes Translation of Novel Cancer-specific Imaging Agents and Techniques to Mediate Successful Image-guided Cancer Interventions
NIH/NCI 464
Yes Yes Yes Cloud-Based Multimodal Data Analysis Software for the Cancer Research Data Commons
NIH/NCI 465
Yes Yes Yes Cancer Prevention and Treatment Clinical Trials Tools for Recruitment and Retention of Diverse Populations
NIH/NIA 010
Yes Yes Yes Technology to facilitate characterization of the exosome in under –resourced populations for AD/ADRD Studies
NIH/NIAID 124
Yes Yes No Development of Next-Generation Devices and Materials-Based Platforms for the Administration of HIV-1 Broadly Neutralizing Antibodies
NIH/NIAID 125
Yes Yes No Development of Long-Acting Treatments for HCV Cure
NIH/NIAID 126
Yes Yes No Rapid Diagnostic Assays for Self-Monitoring of Acute or Rebound HIV-1 Infection
NIH/NIAID 127
Yes Yes No Multiplexed Patient Administered Diagnostics for Hepatitis B, Hepatitis C, and HIV
NIH/NIAID 128
Yes Yes Yes Adjuvant Development for Vaccines for Infectious and Immune-Mediated Diseases
NIH/NIAID 129
Yes Yes Yes Reagents for Immunologic Analysis of Non- mammalian and Underrepresented Mammalian Models
NIH/NIAID 130
Yes Yes Yes Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune-Mediated Diseases
NIH/NIAID 131
Yes Yes No Development of Bacteriophage for Treatment of Mycobacterial Infections
NIH/NIAID 132
Yes Yes No Novel Diagnostic Biomarker Discovery and Validation for Malaria and Select Neglected Tropical Diseases (NTDs)
NIH/NIAID 133
Yes Yes No Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
NIH/NIAID 134
Yes Yes Yes Alternatives to Benzathine Penicillin for Treatment of Syphilis
NIH/NIAID 135
Yes Yes Yes Software or Web Services to Automate Metadata Enrichment and Standardization for Data on Infectious and Immune – Mediated Diseases
NIH/NIAID 136
Yes Yes Yes Software or Web Services to Re-Represent Existing Scientific Data and Knowledge into a Knowledge Graph Format
NIH/NHLBI 115
Yes Yes Yes Clinical Instrument for Para-Hydrogen (pH2) Based Signal Amplification by Reversible Exchange (SABRE) for Hyperpolarizing 13C-Pyruvate and Other Probes for MRI Imaging
NIH/NIAID 108 Yes Yes No Development of Rapid POC Diagnostics for Treponema pallidum NIH/NIMH 001
Yes No No Point-of-Care HIV Viral Load and Drug Adherence Assays
NIH/NIMH 002
Yes No No Development of novel In-vitro and In-vivo Models to support NeuroHIV Research
CDC/NCEZID 031
Yes No No Development of SHERLOCK Assay for Detection of High Threat Orthopoxviruses
CDC/NCHHSTP 055
Yes No No Software Solutions: Bridging the Gap between Public Health and Pharmacies
CDC/NCHHSTP 056
Yes No No EHR Algorithm to Identify Persons with HIV Not in Care
CDC/NCHHSTP 057
Yes No No Device for point-of-care nucleic acid purification and detection of HCV
CDC/NCIRD 036
Yes No No Improved Diagnostic Assays for Measles, Mumps, Rubella, and Varicella
CDC/NCIRD 037
Yes No No Rapid Diagnostic Tests for Measles, Mumps, Rubella, and Varicella
Webinar resources are now available:
Are you ready to get started on winning the non-dilutive funding your company needs?
Recent Comments